Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for AMPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 45.21M
March 31, 2026 29.49M
December 31, 2025 18.53M
September 30, 2025 4.471M
June 30, 2025 38.73M
March 31, 2025 11.00M
December 31, 2024 33.77M
September 30, 2024 31.70M
June 30, 2024 2.683M
March 31, 2024 17.31M
December 31, 2023 -3.56M
September 30, 2023 47.88M
June 30, 2023 -9.725M
March 31, 2023 12.58M
December 31, 2022 16.03M
September 30, 2022 13.09M
June 30, 2022 0.334M
March 31, 2022 -5.208M
December 31, 2021 7.775M
September 30, 2021 2.223M
June 30, 2021 -0.833M
March 31, 2021 3.783M
December 31, 2020 -19.78M
September 30, 2020 4.329M
June 30, 2020 5.756M
Date Value
March 31, 2020 10.95M
December 31, 2019 10.36M
September 30, 2019 4.426M
June 30, 2019 1.073M
March 31, 2019 -15.28M
December 31, 2018 -18.17M
September 30, 2018 -18.61M
June 30, 2018 7.226M
March 31, 2018 7.624M
December 31, 2017 -7.784M
September 30, 2017 7.592M
June 30, 2017 8.978M
March 31, 2017 8.203M
December 31, 2016 -2.56M
September 30, 2016 -13.44M
June 30, 2016 -0.437M
March 31, 2016 5.701M
December 31, 2015 0.659M
September 30, 2015 2.272M
June 30, 2015 -8.418M
March 31, 2015 1.151M
December 31, 2014 0.379M
September 30, 2014 0.355M
June 30, 2014 -36.67M
March 31, 2014 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Supernus Pharmaceuticals, Inc. -4.123M
Liquidia Corp. -1.443M
ANI Pharmaceuticals, Inc. 0.505M
Corcept Therapeutics, Inc. -9.42M
Veru, Inc. -0.001M